Related Experiment Video
Updated: Aug 3, 2025

04:01
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
1.1K
Ferroptosis Regulated by Hypoxia in Cells
Xiangnan Zheng1, Yuqiong Liang1, Cen Zhang1
1College of Biological Science and Engineering, Fuzhou University, Fuzhou 350108, China.
Cells
|April 13, 2023
Summary
Ferroptosis, a cell death form involving iron and lipid peroxides, is regulated by hypoxia. Understanding this link may offer new disease treatment strategies.
Area of Science:
- Cellular biology
- Biochemistry
- Pathophysiology
Background:
- Ferroptosis is a regulated cell death characterized by iron-dependent lipid peroxidation.
- It is distinct from other cell death forms and involves complex regulatory networks.
- Hypoxia, a common condition, influences cellular functions via pathways like hypoxia-inducible factor (HIF).
Purpose of the Study:
- To review the fundamental mechanisms of ferroptosis and hypoxia.
- To explore how hypoxia influences ferroptosis in various conditions.
- To highlight potential therapeutic applications for diseases involving ferroptosis and hypoxia.
Main Methods:
- Literature review of ferroptosis and hypoxia mechanisms.
- Analysis of emerging evidence on hypoxia-ferroptosis interactions.
- Synthesis of findings related to physiological and pathological contexts.
Main Results:
- Ferroptosis is intricately regulated by iron, lipid, and antioxidant pathways.
- Hypoxia modulates ferroptosis in specific cell types and conditions.
- The interplay between hypoxia and ferroptosis is implicated in numerous diseases.
Conclusions:
- The regulation of ferroptosis by hypoxia is a critical area of research.
- Further understanding of this relationship can inform novel therapeutic strategies.
- Targeting the hypoxia-ferroptosis axis holds promise for disease treatment.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Necrosis
4.7K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.7K
Hypoxia
1.1K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
1.1K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Regulation of the Unfolded Protein Response
2.5K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.5K
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K

